Simplify Logo

Full-Time

Account Operations Specialist

NE Region

Confirmed live in the last 24 hours

Adaptive Biotechnologies

Adaptive Biotechnologies

501-1,000 employees

Decodes immune cell receptors for diagnostics

Healthcare
Biotechnology

Compensation Overview

$67.7k - $94.3kAnnually

+ Equity Grant + Bonus

Junior, Mid

Remote in USA

Category
Customer Success
Customer Support
Customer Success & Support
Required Skills
Sales
Communications
Requirements
  • Bachelor’s degree + 2 years of related experience
  • 1-2 years prior Client Services or Customer Training/Support experience is strongly preferred.
  • Proactive approach to work; strong personal drive and desire for feedback.
  • Strong customer and patient focus with a clear understanding of HIPAA requirements.
  • Must have strong analytical and planning skills with keen attention to detail and meticulous data entry skills.
  • Effective project collaborator able to work autonomously to advance the team toward agreed-upon goals.
  • Strong interpersonal and organizational skills with excellent listening, oral and written communication skills.
Responsibilities
  • Support two sales regions to ensure timely access to clonoSEQ ordering for providers and care teams
  • Manage provider onboarding process for expedited ordering and customers who have clonoSEQ integrated in their EMR
  • Build and maintain strategic relationships with customers and drive satisfaction through superior service and execution.
  • Collaborate with Account Operations Leads to manage internal process for addressing institution-specific onboarding requirements.
  • Ensure accurate and timely reporting of information related to new prospects.
  • Serve as customer liaison for priority internal initiatives requiring customer engagement.
  • Educate customers on new support offerings to maximize brand performance.
  • Manage clonoSEQ collection kit inventory in your two regions
  • Collaborate with the Clinical Services team to ensure efficient and effective communication with clinicians and their care team.
  • Serve as a point of customer escalation engagement
  • Contribute to a culture of success and ongoing business and goal achievement.
  • Support patient pull through efforts with timely customer follow-up and reporting.
Adaptive Biotechnologies

Adaptive Biotechnologies

View

Adaptive Biotechnologies focuses on using the immune system to improve disease diagnosis and treatment. The company decodes genetic information from immune cell receptors, which are essential for the immune system's ability to identify and respond to diseases. One of their key projects is the ImmuneRACE study, which analyzes blood samples and swabs from participants to understand how the immune system reacts to COVID-19. This research aims to enhance diagnostics, treatments, and vaccines for the virus. Adaptive Biotechnologies generates revenue by partnering with pharmaceutical companies, licensing their technology, and offering diagnostic services. Their goal is to leverage immune system data to advance healthcare solutions for various diseases.

Company Stage

IPO

Total Funding

$575.5M

Headquarters

Seattle, Washington

Founded

2009

Growth & Insights
Headcount

6 month growth

-4%

1 year growth

-8%

2 year growth

-10%
Simplify Jobs

Simplify's Take

What believers are saying

  • Adaptive Biotechnologies' partnerships with pharmaceutical companies and healthcare providers offer significant growth opportunities and revenue streams.
  • Winning the Workplace of the Year Award highlights their strong company culture and employee satisfaction, making it an attractive place to work.
  • Their collaboration with BeiGene on minimal residual disease measurement could lead to groundbreaking advancements in cancer treatment.

What critics are saying

  • The departure of key board members like Kevin Conroy and Leslie Trigg could lead to strategic instability.
  • The highly competitive biotechnology sector requires continuous innovation to maintain market position.

What makes Adaptive Biotechnologies unique

  • Adaptive Biotechnologies leverages the genetic information of immune cell receptors to develop advanced diagnostic tools and treatments, setting it apart from traditional biotech firms.
  • Their ImmuneRACE study, focusing on COVID-19 immune response, showcases their commitment to addressing current global health challenges.
  • The integration of their clonoSEQ® assay with Epic systems enhances their diagnostic capabilities, providing a seamless experience for healthcare providers.